Prolong Pharmaceuticals, Inc.

Development and licensing of long acting versions of proteins, either novel or generic, using PEG technology.

Activity:

- Clinical Trials
- Contract Manufacturing
- Contract Research
- Manufacturing
- Research & Development

Product / Technology type(s) covered:

- Drug delivery
- Pharmaceuticals / Therapeutics

Therapeutic targets:

- Cancer
- Oncology

Markets Covered

a. HeadQuarter: United States of America

b. Continent(s) active: North America , Far East , Near/Middle East , Central/South America , Europe , Africa

c. Countries active: All

Corporate data:

Number of Employees: 2

Turnover:

Amount:	Year:	Currency:
-	2002	US Dollar

Year founded: 2002